These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 28247082

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 3. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL.
    Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Beyond the randomized clinical trial: citrate for continuous renal replacement therapy in clinical practice.
    Tovey L, Dickie H, Gangi S, Terblanche M, McKenzie C, Beale R, Treacher D, Ostermann M.
    Nephron Clin Pract; 2013 Jul; 124(1-2):119-23. PubMed ID: 24281234
    [Abstract] [Full Text] [Related]

  • 6. Citrate and low-dose heparin combined anticoagulation in pediatric continuous renal replacement therapy.
    Zhu D, He J, Xiao Z, Zhou X, Zhang X.
    Sci Rep; 2024 Jun 12; 14(1):13504. PubMed ID: 38866989
    [Abstract] [Full Text] [Related]

  • 7. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA, Lilien M, van Kessel IA, Veldhoen ES, Wösten-van Asperen RM, van Gestel JPJ.
    Pediatr Nephrol; 2017 Oct 12; 32(10):1971-1978. PubMed ID: 28578542
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. We Use Heparin as the Anticoagulant for CRRT.
    Karakala N, Tolwani A.
    Semin Dial; 2016 Jul 12; 29(4):272-4. PubMed ID: 27082940
    [Abstract] [Full Text] [Related]

  • 12. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
    Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE.
    Crit Care; 2021 Aug 19; 25(1):299. PubMed ID: 34412667
    [Abstract] [Full Text] [Related]

  • 13. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun 19; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?
    Agarwal B, Shaw S, Shankar Hari M, Burroughs AK, Davenport A.
    J Hepatol; 2009 Sep 19; 51(3):504-9. PubMed ID: 19615775
    [Abstract] [Full Text] [Related]

  • 17. Continuous Renal Replacement Therapy in Venovenous Extracorporeal Membrane Oxygenation: A Retrospective Study on Regional Citrate Anticoagulation.
    Giani M, Scaravilli V, Stefanini F, Valsecchi G, Rona R, Grasselli G, Bellani G, Pesenti AM, Foti G.
    ASAIO J; 2020 Mar 19; 66(3):332-338. PubMed ID: 31045918
    [Abstract] [Full Text] [Related]

  • 18. Filter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit Survival.
    Miklaszewska M, Korohoda P, Zachwieja K, Kobylarz K, Stefanidis CJ, Sobczak A, Drożdż D.
    Kidney Blood Press Res; 2017 Mar 19; 42(2):327-337. PubMed ID: 28578343
    [Abstract] [Full Text] [Related]

  • 19. A Comparison of the Anticoagulation Efficacy and Safety of Epoprostenol to Heparin and Citrate in Children Receiving Continuous Renal Replacement Therapy.
    Sondhi E, Stewart M, Harper J, Konyk L, McSteen C, Crowley KL, Kim-Campbell N, Fabio A, Fuhrman DY.
    Blood Purif; 2024 Mar 19; 53(10):838-846. PubMed ID: 38991509
    [Abstract] [Full Text] [Related]

  • 20. Citrate anticoagulation for continuous renal replacement therapy in small children.
    Soltysiak J, Warzywoda A, Kociński B, Ostalska-Nowicka D, Benedyk A, Silska-Dittmar M, Zachwieja J.
    Pediatr Nephrol; 2014 Mar 19; 29(3):469-75. PubMed ID: 24337319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.